FDA Approval For SEDASYS® Sedation System

J&J division, Sedasys says its sedation system is indicated for the intravenous administration of 1% (10 mg/mL) propofol injectable emulsion for the initiation and maintenance of minimal-to-moderate sedation in defined patient groups undergoing colonoscopy and esophagogastroduodenoscopy procedures.

FDA Grants Premarket Approval (PMA) For The SEDASYS® System For Healthy Patients Undergoing Sedation During Routine Colonoscopy And EGD Procedures (via PR Newswire)

– Reduces risks associated with oversedation, facilitates faster patient recovery and increases physician satisfaction – Download image CINCINNATI, May 3, 2013 /PRNewswire/ — Sedasys, a Division of Ethicon Endo-Surgery, Inc. (Ethicon), today announced that the U.S. Food and Drug Administration (FDA…

published: May 7, 2013 in: Anaesthesia, Approval/Clearance, Johnson & Johnson

Most read

Latest

^